Mexico - Delayed Quote MXN

Amedisys, Inc. (AMED.MX)

Compare
1,887.93 0.00 (0.00%)
As of August 7 at 8:50 AM CST. Market Open.
Loading Chart for AMED.MX
DELL
  • Previous Close 1,887.93
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 1,887.93 - 1,887.93
  • 52 Week Range 1,566.00 - 1,887.93
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 62.751B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 33.44
  • EPS (TTM) 56.45
  • Earnings Date Feb 19, 2025 - Feb 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

www.amedisys.com

19,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMED.MX

View More

Performance Overview: AMED.MX

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMED.MX
20.56%
S&P 500
25.08%

1-Year Return

AMED.MX
20.56%
S&P 500
31.46%

3-Year Return

AMED.MX
49.86%
S&P 500
26.99%

5-Year Return

AMED.MX
37.67%
S&P 500
92.23%

Compare To: AMED.MX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMED.MX

View More

Valuation Measures

Annual
As of 11/21/2024
  • Market Cap

    59.91B

  • Enterprise Value

    64.42B

  • Trailing P/E

    33.44

  • Forward P/E

    18.80

  • PEG Ratio (5yr expected)

    1.31

  • Price/Sales (ttm)

    1.35

  • Price/Book (mrq)

    2.73

  • Enterprise Value/Revenue

    1.51

  • Enterprise Value/EBITDA

    14.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.57%

  • Return on Assets (ttm)

    6.27%

  • Return on Equity (ttm)

    7.21%

  • Revenue (ttm)

    2.32B

  • Net Income Avi to Common (ttm)

    82.93M

  • Diluted EPS (ttm)

    56.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.45M

  • Total Debt/Equity (mrq)

    38.96%

  • Levered Free Cash Flow (ttm)

    264.57M

Research Analysis: AMED.MX

View More

Company Insights: AMED.MX

Research Reports: AMED.MX

View More